Beyond glucose regulation, GLP-1 receptor agonists slow gastric emptying, which helps people feel fuller for longer periods and reduces appetite through effects on brain centers that control hunger
For some, it may take several months to see the full effect
Coverage rules can change depending on state funding and policy updates, so its best to check directly with your states Medicaid program to see whats covered and what criteria apply
Rybelsus Rybelsus is the only GLP-1 receptor agonist available in pill form, prescribed mainly for type 2 diabetes and sometimes used off-label for weight loss
Others have waited two to three weeks, sometimes longer
In adults without diabetes, a 7.2 mg dose of semaglutide caused an average weight loss of nearly 19%, surpassing the 16% seen with the 2.4 mg dose and 4% with placebo